GR3034583T3 - Oral fast-dissolving compositions for dopamine agonists - Google Patents

Oral fast-dissolving compositions for dopamine agonists

Info

Publication number
GR3034583T3
GR3034583T3 GR20000402272T GR20000402272T GR3034583T3 GR 3034583 T3 GR3034583 T3 GR 3034583T3 GR 20000402272 T GR20000402272 T GR 20000402272T GR 20000402272 T GR20000402272 T GR 20000402272T GR 3034583 T3 GR3034583 T3 GR 3034583T3
Authority
GR
Greece
Prior art keywords
active ingredient
composition
carrier
dopamine agonists
solvent
Prior art date
Application number
GR20000402272T
Other languages
English (en)
Inventor
Edward Stewart Johnson
Anthony Clarke
Richard David Green
Original Assignee
Scherer Ltd R P
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Scherer Ltd R P filed Critical Scherer Ltd R P
Publication of GR3034583T3 publication Critical patent/GR3034583T3/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/485—Morphinan derivatives, e.g. morphine, codeine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nutrition Science (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Emergency Medicine (AREA)
  • Physiology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Zoology (AREA)
  • Psychology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
GR20000402272T 1995-08-18 2000-10-09 Oral fast-dissolving compositions for dopamine agonists GR3034583T3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9517062.7A GB9517062D0 (en) 1995-08-18 1995-08-18 Pharmaceutical compositions
PCT/GB1996/002020 WO1997006786A1 (en) 1995-08-18 1996-08-16 Oral fast-dissolving compositions for dopamine agonists

Publications (1)

Publication Number Publication Date
GR3034583T3 true GR3034583T3 (en) 2001-01-31

Family

ID=10779521

Family Applications (1)

Application Number Title Priority Date Filing Date
GR20000402272T GR3034583T3 (en) 1995-08-18 2000-10-09 Oral fast-dissolving compositions for dopamine agonists

Country Status (27)

Country Link
US (1) US6316027B1 (el)
EP (1) EP0850050B1 (el)
JP (1) JPH11511162A (el)
AT (1) ATE196249T1 (el)
AU (1) AU709641B2 (el)
BG (1) BG63188B1 (el)
BR (1) BR9610424A (el)
CA (1) CA2229597C (el)
CZ (1) CZ293129B6 (el)
DE (1) DE69610323T2 (el)
DK (1) DK0850050T3 (el)
EE (1) EE03471B1 (el)
ES (1) ES2151672T3 (el)
GB (1) GB9517062D0 (el)
GR (1) GR3034583T3 (el)
HU (1) HU222197B1 (el)
MX (1) MX9801305A (el)
NO (1) NO313368B1 (el)
NZ (1) NZ315740A (el)
PL (1) PL187718B1 (el)
PT (1) PT850050E (el)
RO (1) RO119066B1 (el)
RU (1) RU2189226C2 (el)
SK (1) SK283597B6 (el)
UA (1) UA64700C2 (el)
WO (1) WO1997006786A1 (el)
ZA (1) ZA967032B (el)

Families Citing this family (148)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6121276A (en) * 1994-04-22 2000-09-19 Pentech Pharmaceuticals, Inc. Apomorphine-containing dosage forms for ameliorating male erectile dysfunction
US5888534A (en) * 1995-06-13 1999-03-30 Pentech Pharmaceuticals, Inc. Controlled release of drugs delivered by sublingual or buccal administration
GB9517062D0 (en) 1995-08-18 1995-10-25 Scherer Ltd R P Pharmaceutical compositions
GB9700878D0 (en) * 1997-01-17 1997-03-05 Scherer Ltd R P Dosage forms and method for ameliorating male erectile dysfunction
US20040023948A1 (en) * 1997-03-24 2004-02-05 Green Richard David Fast-dispersing dosage form containing 5-HT1 agonists
ATE333279T1 (de) * 1997-05-19 2006-08-15 Zonagen Inc Kombinationstherapie zur modulation der humanen sexualreaktion
WO1999001108A1 (en) 1997-07-01 1999-01-14 Implico B.V. Quick release compositions
US6974590B2 (en) 1998-03-27 2005-12-13 Cima Labs Inc. Sublingual buccal effervescent
US20030118645A1 (en) * 1998-04-29 2003-06-26 Pather S. Indiran Pharmaceutical compositions for rectal and vaginal administration
US20030091629A1 (en) 1998-03-27 2003-05-15 Cima Labs Inc. Sublingual buccal effervescent
GB9904911D0 (en) * 1999-03-03 1999-04-28 Scherer Ltd R P Pharmaceutical compositions
GB9908014D0 (en) * 1999-04-08 1999-06-02 Scherer Corp R P Pharmaceutical compositions
CZ20022245A3 (cs) * 1999-12-30 2002-10-16 Tap Holdings, Inc. Orální mukózní dávkovací formy apomorfinu
HUP0303355A3 (en) * 2000-08-08 2005-06-28 Teva Pharma Stable pergolide mesylate and process for making same
IL154378A0 (en) * 2000-08-16 2003-09-17 Upjohn Co Compounds for the treatment of addictive disorders
SE0002934D0 (sv) 2000-08-17 2000-08-17 Axon Biochemicals Bv New aporphine esters and in their use in therapy
SE0102036D0 (sv) * 2001-06-08 2001-06-08 Axon Biochemicals Bv Pharmaceutical formulation for the efficient administration of apomorphine, 6aR- (-) -N- Propyl- norapomorphine and their derivatives and pro-drugs thereof
DE10107659B4 (de) * 2001-02-19 2008-03-13 Lts Lohmann Therapie-Systeme Ag Mucoadhäsive zerfallsfähige Arzneizubereitung zur Wirkstoffverabreichung in der Veterinär- und Humanmedizin
US20030068356A1 (en) * 2001-07-10 2003-04-10 Pather S. Indiran Sequential drug delivery systems
FR2834894B1 (fr) * 2002-01-21 2004-02-27 Servier Lab Composition pharmaceutique orodispersible de piribedil
CN1649600A (zh) 2002-02-28 2005-08-03 A&D生物科学公司 氟西汀及类似物的糖醛酰胺、苷和原酸酯苷及其应用
EP1496915A1 (en) * 2002-03-19 2005-01-19 Brain 'N' Beyond Biotech Glycoside and orthoester glycoside derivatives of apomorphine, analogs, and uses thereof
WO2003079980A2 (en) * 2002-03-19 2003-10-02 A & D Bioscience, Inc. Caboxylic acid glycuronides, glycosamides and glycosides of quinolones, penicillins, analogs, and uses thereof
KR20040098050A (ko) * 2002-04-05 2004-11-18 유로-셀띠끄 소시에떼 아노님 옥시코돈 및 날록손을 포함하는 약제학적 제제
US20050255038A1 (en) * 2002-04-12 2005-11-17 A And D Bioscience, Inc. Conjugates comprising cancer cell specific ligands, a sugar and diagnostic agents and uses thereof
AU2003241322A1 (en) * 2002-04-30 2003-11-17 Npd Llc Multi-phasic delivery via transmucosal absorption of antiemetic medicaments
EP1549323A2 (en) * 2002-05-07 2005-07-06 A & D Bioscience, Inc. Conjugates comprising central nervous system active drug
WO2004000223A2 (en) * 2002-06-20 2003-12-31 Orapharma, Inc. Rapidly disintegrating formulations for treating or preventing mucositis
US20050215487A1 (en) * 2002-06-27 2005-09-29 Holick Michael F Conjugates comprising an nsaid and a sugar and uses thereof
GB0217056D0 (en) * 2002-07-23 2002-08-28 Ass Octel Use
US8821915B2 (en) 2002-08-09 2014-09-02 Veroscience, Llc Therapeutic process for the treatment of the metabolic syndrome and associated metabolic disorders
GB0226076D0 (en) * 2002-11-08 2002-12-18 Rp Scherer Technologies Inc Improved formulations containing substituted imidazole derivatives
US20040156894A1 (en) * 2003-02-07 2004-08-12 Grother Leon Paul Use of edible acids in fast-dispersing pharmaceutical solid dosage forms
PT2316456T (pt) 2003-04-29 2017-09-05 Orexigen Therapeutics Inc Composições para afetar a perda de peso compreendendo naltrexona e bupropion
JP5244318B2 (ja) * 2003-12-31 2013-07-24 シーマ・ラブス、インコーポレイテッド 発泡性経口アヘン薬投薬形態およびアヘン薬の投与方法
WO2005065317A2 (en) * 2003-12-31 2005-07-21 Cima Labs Inc. Effervescent oral fentanyl dosage form
EA010826B1 (ru) * 2003-12-31 2008-12-30 Сайма Лэбс Инк. Лекарственная форма фентанила для перорального применения, способ ее получения и способы лечения
US7576073B2 (en) 2004-05-28 2009-08-18 UNIVERSITé LAVAL Combined therapy for the treatment of parkinson's disease
CA2568445C (en) * 2004-06-17 2011-05-24 Merz Pharma Gmbh & Co. Kgaa Immediate release formulations of memantine oral dosage forms
EP1812081A1 (en) * 2004-11-03 2007-08-01 Clera Inc. Method to detect dopamine receptors in the functional d2high state
NZ560826A (en) * 2005-03-28 2009-06-26 Orexo Ab Composition comprising weak acid and particulate L-dopa useful in the treatment of parkinson's disease
GB0509317D0 (en) * 2005-05-06 2005-06-15 Clarke Anthony Pharmaceutical formulation of apomorphine
US20070128285A1 (en) * 2005-07-12 2007-06-07 Chikara Jin Pharmaceutical composition for oral administration
US20070020186A1 (en) * 2005-07-22 2007-01-25 Alpex Pharma S.A. Solid dosage formulations of narcotic drugs having improved buccal adsorption
EP1937270A1 (en) * 2005-09-21 2008-07-02 Brystol-Myers Squibb Company Oral administration of n-(2-chloro-6-methylphenyl)-2-[[6-4-(2-hydroxyethyl)-1-piperazinyl]-2-methyl-4-pyrimidinyl]amino]-1,3-thiazole-5-carboxamide and salts thereof
JP5180092B2 (ja) 2005-11-22 2013-04-10 オレキシジェン・セラピューティクス・インコーポレーテッド インスリン感受性を増すための組成物および方法
US8916195B2 (en) 2006-06-05 2014-12-23 Orexigen Therapeutics, Inc. Sustained release formulation of naltrexone
AR061485A1 (es) * 2006-06-15 2008-08-27 Serenex Inc Composiciones estabilizadas de tetraciclina
DE102006027793A1 (de) * 2006-06-16 2007-12-20 Lts Lohmann Therapie-Systeme Ag Opioid-Kombinations-Wafer
EP2043613A1 (en) * 2006-07-14 2009-04-08 Fmc Corporation Solid form
EP1897543A1 (en) 2006-08-30 2008-03-12 Euro-Celtique S.A. Buprenorphine- wafer for drug substitution therapy
AU2007319472B2 (en) 2006-11-09 2013-01-17 Nalpropion Pharmaceuticals Llc Methods Of Administering Weight Loss Medications
US20080311162A1 (en) * 2007-05-16 2008-12-18 Olivia Darmuzey Solid form
US8741918B2 (en) 2007-06-21 2014-06-03 Veroscience Llc Parenteral formulations of dopamine agonists
US20100035886A1 (en) 2007-06-21 2010-02-11 Veroscience, Llc Parenteral formulations of dopamine agonists
US20110111014A1 (en) * 2007-06-26 2011-05-12 Parkinson's Institute Methods and compositions for treatment of neurological disorders
US20090004248A1 (en) * 2007-06-29 2009-01-01 Frank Bunick Dual portion dosage lozenge form
US20090004231A1 (en) 2007-06-30 2009-01-01 Popp Shane M Pharmaceutical dosage forms fabricated with nanomaterials for quality monitoring
MX2010012909A (es) 2008-05-30 2011-02-25 Orexigen Therapeutics Inc Metodos para tratamiento de condiciones de grasa visceral.
WO2010019856A1 (en) * 2008-08-15 2010-02-18 The Mclean Hospital Corporation Methods and kits for treatings stroke and other neurological conditions
DE102009036285A1 (de) * 2008-10-13 2010-04-15 Illinois Tool Works Inc., Glenview Verfahren zur Herstellung eines Bohrers, insbesondere eines Gesteinsbohrers
US20100116281A1 (en) 2008-11-07 2010-05-13 Jerry Wayne Marshall Tobacco products and processes
US9352025B2 (en) 2009-06-05 2016-05-31 Veroscience Llc Combination of dopamine agonists plus first phase insulin secretagogues for the treatment of metabolic disorders
EP2952191B1 (en) 2009-06-12 2018-08-22 Sunovion Pharmaceuticals Inc. Sublingual apomorphine
US8545879B2 (en) 2009-08-31 2013-10-01 Wilmington Pharmaceuticals, Llc Fast disintegrating compositions of meloxicam
BR122022005637B1 (pt) 2009-10-01 2023-03-07 Adare Pharmaceuticals, Inc Composição farmacêutica líquida não aquosa
PL2493457T3 (pl) 2009-10-30 2018-01-31 Ix Biopharma Ltd Szybko rozpuszczalna stała postać dawkowana
EP3659604A1 (en) 2010-01-11 2020-06-03 Nalpropion Pharmaceuticals, Inc. Methods of providing weight loss therapy in patients with major depression
US9675102B2 (en) 2010-09-07 2017-06-13 R. J. Reynolds Tobacco Company Smokeless tobacco product comprising effervescent composition
JP6061859B2 (ja) * 2010-10-08 2017-01-18 アール．ピー． シェーラー テクノロジーズ エルエルシー デンプンを使用する経口ワクチン速溶性剤型
CA3115378A1 (en) 2010-12-16 2012-06-21 Sunovion Pharmaceuticals Inc. Sublingual films comprising apomorphine and an organic base
US10881132B2 (en) 2011-12-14 2021-01-05 R.J. Reynolds Tobacco Company Smokeless tobacco product comprising effervescent composition
HUE049859T2 (hu) 2012-06-06 2020-10-28 Nalpropion Pharmaceuticals Llc Készítmény magas kardiovaszkuláris kockázatnak kitett páciensekben túlsúly és elhízás kezelésére szolgáló eljárásban történõ alkalmazásra
WO2014150979A2 (en) 2013-03-15 2014-09-25 R. J. Reynolds Tobacco Company Heating elements formed from a sheet of a material, inputs and methods for the production of atomizers, cartridge for an aerosol delivery device and method for assembling a cartridge for a smoking article
WO2015034678A2 (en) 2013-09-06 2015-03-12 Aptalis Pharmatech, Inc. Corticosteroid containing orally disintegrating tablet compositions for eosinophilic esophagitis
MX2016006087A (es) * 2013-11-11 2016-08-12 Impax Laboratories Inc Formulaciones de desintegracion rapida y metodos de uso.
US8969371B1 (en) 2013-12-06 2015-03-03 Orexigen Therapeutics, Inc. Compositions and methods for weight loss in at risk patient populations
WO2016172095A1 (en) 2015-04-21 2016-10-27 Cynapsus Therapeutics, Inc. Methods of treating parkinson's disease by administration of apomorphine to an oral mucosa
US10611505B2 (en) 2015-05-04 2020-04-07 Rai Strategic Holdings, Inc. Dispensing machine for aerosol precursor
US10238145B2 (en) 2015-05-19 2019-03-26 Rai Strategic Holdings, Inc. Assembly substation for assembling a cartridge for a smoking article
US20170112194A1 (en) 2015-10-21 2017-04-27 Rai Strategic Holdings, Inc. Rechargeable lithium-ion capacitor for an aerosol delivery device
US10820630B2 (en) 2015-11-06 2020-11-03 Rai Strategic Holdings, Inc. Aerosol delivery device including a wirelessly-heated atomizer and related method
US10104912B2 (en) 2016-01-20 2018-10-23 Rai Strategic Holdings, Inc. Control for an induction-based aerosol delivery device
US11207478B2 (en) 2016-03-25 2021-12-28 Rai Strategic Holdings, Inc. Aerosol production assembly including surface with micro-pattern
US10334880B2 (en) 2016-03-25 2019-07-02 Rai Strategic Holdings, Inc. Aerosol delivery device including connector comprising extension and receptacle
US10405579B2 (en) 2016-04-29 2019-09-10 Rai Strategic Holdings, Inc. Methods for assembling a cartridge for an aerosol delivery device, and associated systems and apparatuses
US11019847B2 (en) 2016-07-28 2021-06-01 Rai Strategic Holdings, Inc. Aerosol delivery devices including a selector and related methods
TWI728172B (zh) 2016-08-18 2021-05-21 美商愛戴爾製藥股份有限公司 治療嗜伊紅性食道炎之方法
US10477896B2 (en) 2016-10-12 2019-11-19 Rai Strategic Holdings, Inc. Photodetector for measuring aerosol precursor composition in an aerosol delivery device
US20180132528A1 (en) 2016-11-14 2018-05-17 Rai Strategic Holdings, Inc. Photoelectric proximity sensor for gesture-based control of an aerosol delivery device
US20180132529A1 (en) 2016-11-14 2018-05-17 Rai Strategic Holdings, Inc. Aerosol delivery device with integrated wireless connectivity for temperature monitoring
US10524508B2 (en) 2016-11-15 2020-01-07 Rai Strategic Holdings, Inc. Induction-based aerosol delivery device
US10537137B2 (en) 2016-11-22 2020-01-21 Rai Strategic Holdings, Inc. Rechargeable lithium-ion battery for an aerosol delivery device
JP7110194B2 (ja) 2016-12-01 2022-08-01 アール・エイ・アイ・ストラテジック・ホールディングス・インコーポレイテッド エアロゾル送達装置用の再充電可能なリチウムイオンキャパシタ
JP7008070B2 (ja) 2016-12-02 2022-01-25 アール・エイ・アイ・ストラテジック・ホールディングス・インコーポレイテッド エアロゾル送達装置のための誘導充電
US11013266B2 (en) 2016-12-09 2021-05-25 Rai Strategic Holdings, Inc. Aerosol delivery device sensory system including an infrared sensor and related method
US10517326B2 (en) 2017-01-27 2019-12-31 Rai Strategic Holdings, Inc. Secondary battery for an aerosol delivery device
US10759554B2 (en) 2017-02-02 2020-09-01 Rai Strategic Holdings, Inc. Dispenser unit for aerosol precursor
US10827783B2 (en) 2017-02-27 2020-11-10 Rai Strategic Holdings, Inc. Digital compass for an aerosol delivery device
US10314340B2 (en) 2017-04-21 2019-06-11 Rai Strategic Holdings, Inc. Refillable aerosol delivery device and related method
US11297876B2 (en) 2017-05-17 2022-04-12 Rai Strategic Holdings, Inc. Aerosol delivery device
US10517330B2 (en) 2017-05-23 2019-12-31 RAI Stategic Holdings, Inc. Heart rate monitor for an aerosol delivery device
US10349674B2 (en) 2017-07-17 2019-07-16 Rai Strategic Holdings, Inc. No-heat, no-burn smoking article
US11337456B2 (en) 2017-07-17 2022-05-24 Rai Strategic Holdings, Inc. Video analytics camera system for an aerosol delivery device
US10791761B2 (en) 2017-08-17 2020-10-06 Rai Strategic Holdings, Inc. Microtextured liquid transport element for aerosol delivery device
US11039645B2 (en) 2017-09-19 2021-06-22 Rai Strategic Holdings, Inc. Differential pressure sensor for an aerosol delivery device
US10505383B2 (en) 2017-09-19 2019-12-10 Rai Strategic Holdings, Inc. Intelligent charger for an aerosol delivery device
US10660370B2 (en) 2017-10-12 2020-05-26 Rai Strategic Holdings, Inc. Aerosol delivery device including a control body, an atomizer body, and a cartridge and related methods
US20190116863A1 (en) 2017-10-24 2019-04-25 Rai Strategic Holdings, Inc. Method for formulating aerosol precursor for aerosol delivery device
US10806181B2 (en) 2017-12-08 2020-10-20 Rai Strategic Holdings, Inc. Quasi-resonant flyback converter for an induction-based aerosol delivery device
US10555558B2 (en) 2017-12-29 2020-02-11 Rai Strategic Holdings, Inc. Aerosol delivery device providing flavor control
US10813385B2 (en) 2018-03-09 2020-10-27 Rai Strategic Holdings, Inc. Buck regulator with operational amplifier feedback for an aerosol delivery device
US11206864B2 (en) 2018-03-26 2021-12-28 Rai Strategic Holdings, Inc. Aerosol delivery device providing flavor control
US10959459B2 (en) 2018-05-16 2021-03-30 Rai Strategic Holdings, Inc. Voltage regulator for an aerosol delivery device
US11094993B2 (en) 2018-08-10 2021-08-17 Rai Strategic Holdings, Inc. Charge circuitry for an aerosol delivery device
US10939707B2 (en) 2018-08-23 2021-03-09 Rai Strategic Holdings, Inc. Aerosol delivery device with segmented electrical heater
US11592793B2 (en) 2018-11-19 2023-02-28 Rai Strategic Holdings, Inc. Power control for an aerosol delivery device
US11614720B2 (en) 2018-11-19 2023-03-28 Rai Strategic Holdings, Inc. Temperature control in an aerosol delivery device
US11753750B2 (en) 2018-11-20 2023-09-12 R.J. Reynolds Tobacco Company Conductive aerosol generating composite substrate for aerosol source member
US11547816B2 (en) 2018-11-28 2023-01-10 Rai Strategic Holdings, Inc. Micropump for an aerosol delivery device
US11096419B2 (en) 2019-01-29 2021-08-24 Rai Strategic Holdings, Inc. Air pressure sensor for an aerosol delivery device
US20200245696A1 (en) 2019-02-06 2020-08-06 Rai Strategic Holdings, Inc. Buck-boost regulator circuit for an aerosol delivery device
US11456480B2 (en) 2019-02-07 2022-09-27 Rai Strategic Holdings, Inc. Non-inverting amplifier circuit for an aerosol delivery device
US20200278707A1 (en) 2019-03-01 2020-09-03 Rai Strategic Holdings, Inc. Temperature control circuitry for an aerosol delivery device
US11324249B2 (en) 2019-03-06 2022-05-10 R.J. Reynolds Tobacco Company Aerosol delivery device with nanocellulose substrate
US20200281250A1 (en) 2019-03-08 2020-09-10 Rai Strategic Holdings, Inc. Method for hydrolysis of lactic acid for aerosol delivery device
US11200770B2 (en) 2019-04-02 2021-12-14 Rai Strategic Holdings, Inc. Functional control and age verification of electronic devices through visual communication
US11676438B2 (en) 2019-04-02 2023-06-13 Rai Strategic Holdings, Inc. Authentication and age verification for an aerosol delivery device
US11935350B2 (en) 2019-04-02 2024-03-19 Rai Strategic Holdings, Inc. Functional control and age verification of electronic devices through speaker communication
US11783395B2 (en) 2019-04-24 2023-10-10 Rai Strategic Holdings, Inc. Decentralized identity storage for tobacco products
US11690405B2 (en) 2019-04-25 2023-07-04 Rai Strategic Holdings, Inc. Artificial intelligence in an aerosol delivery device
US20200359703A1 (en) 2019-05-17 2020-11-19 Rai Strategic Holdings, Inc. Age verification with registered cartridges for an aerosol delivery device
US12022859B2 (en) 2019-07-18 2024-07-02 R.J. Reynolds Tobacco Company Thermal energy absorbers for tobacco heating products
CN115605105A (zh) 2019-08-29 2023-01-13 莱战略控股公司（Us） 双腔室气溶胶分配器
GB201912686D0 (en) 2019-09-04 2019-10-16 Reown Pharma Inc Pharmaceutical composition
US11785991B2 (en) 2019-10-04 2023-10-17 Rai Strategic Holdings, Inc. Use of infrared temperature detection in an aerosol delivery device
US11470689B2 (en) 2019-10-25 2022-10-11 Rai Strategic Holdings, Inc. Soft switching in an aerosol delivery device
US20230024704A1 (en) 2019-11-18 2023-01-26 Rai Strategic Holdings, Inc. Security tag
KR20220133203A (ko) 2019-12-30 2022-10-04 레이 스트라티직 홀딩스, 인크. 에어로졸 전달 장치용 심박수 모니터
US20210321655A1 (en) 2020-04-16 2021-10-21 R.J. Reynolds Tobacco Company Aerosol delivery device including a segregated substrate
US20210321674A1 (en) 2020-04-21 2021-10-21 Rai Strategic Holdings, Inc. Pressure-sensing user interface for an aerosol delivery device
US11839240B2 (en) 2020-04-29 2023-12-12 Rai Strategic Holdings, Inc. Piezo sensor for a power source
WO2021250516A1 (en) 2020-06-08 2021-12-16 Nicoventures Trading Limited Effervescent oral composition comprising an active ingredient
US11771132B2 (en) 2020-08-27 2023-10-03 Rai Strategic Holdings, Inc. Atomization nozzle for aerosol delivery device
US11771136B2 (en) 2020-09-28 2023-10-03 Rai Strategic Holdings, Inc. Aerosol delivery device
US11672761B2 (en) 2020-11-16 2023-06-13 Orcosa Inc. Rapidly infusing platform and compositions for therapeutic treatment in humans
US20220183389A1 (en) 2020-12-11 2022-06-16 Rai Strategic Holdings, Inc. Sleeve for smoking article
CA3216322A1 (en) 2021-04-22 2022-10-27 Nicoventures Trading Limited Effervescent oral composition

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE45770B1 (en) * 1976-10-06 1982-11-17 Wyeth John & Brother Ltd Pharmaceutical dosage forms
DE3216869A1 (de) * 1982-05-03 1983-11-03 Schering AG, 1000 Berlin und 4709 Bergkamen Synergistische kombination mit zytostatischer wirkung
US5288497A (en) * 1985-05-01 1994-02-22 The University Of Utah Compositions of oral dissolvable medicaments
US5785989A (en) 1985-05-01 1998-07-28 University Utah Research Foundation Compositions and methods of manufacturing of oral dissolvable medicaments
NZ220599A (en) * 1986-06-16 1990-10-26 Merck & Co Inc Controlled release oral dosage formulation of carbidopa and levodopa
US4855326A (en) * 1987-04-20 1989-08-08 Fuisz Pharmaceutical Ltd. Rapidly dissoluble medicinal dosage unit and method of manufacture
GB8712073D0 (en) * 1987-05-21 1987-06-24 Smith Kline French Lab Medicament
US5234957A (en) * 1991-02-27 1993-08-10 Noven Pharmaceuticals, Inc. Compositions and methods for topical administration of pharmaceutically active agents
US5073374A (en) * 1988-11-30 1991-12-17 Schering Corporation Fast dissolving buccal tablet
US5079018A (en) * 1989-08-14 1992-01-07 Neophore Technologies, Inc. Freeze dry composition and method for oral administration of drugs, biologicals, nutrients and foodstuffs
EP0494972B1 (en) 1989-10-02 1996-11-27 Cima Labs, Inc. Effervescent dosage form and method of administering same
GB9015095D0 (en) * 1990-07-09 1990-08-29 Smith Kline French Lab Therapeutic method
GB9216297D0 (en) * 1991-08-15 1992-09-16 Ici Plc Therapeutic agents
PL171695B1 (en) * 1991-11-04 1997-06-30 Fuisz Technologies Ltd Chewing gum
JP2807346B2 (ja) * 1991-12-24 1998-10-08 山之内製薬株式会社 口腔内崩壊製剤及びその製造法
JP3069458B2 (ja) * 1992-01-29 2000-07-24 武田薬品工業株式会社 口腔内崩壊型錠剤およびその製造法
HUT75616A (en) * 1992-03-17 1997-05-28 Pfizer Method for prooucing porous delivery devices
US5298261A (en) 1992-04-20 1994-03-29 Oregon Freeze Dry, Inc. Rapidly distintegrating tablet
IL105553A (en) * 1992-05-06 1998-01-04 Janssen Pharmaceutica Inc Solid dosage forms consisting of a porous network of matrix that releases a substance that dissipates rapidly in water
CA2095776C (en) * 1992-05-12 2007-07-10 Richard C. Fuisz Rapidly dispersable compositions containing polydextrose
IL108366A (en) * 1993-03-11 1999-11-30 Taro Vit Ind Ltd Semi-solid pharmaceutical compounds and a device for their use
EP0865789B1 (en) * 1993-03-26 2005-03-16 Franciscus Wilhelmus Henricus Maria Merkus Pharmaceutical compositions for intranasal administration of dihydroergotamine
DE4320678C2 (de) 1993-06-22 1996-04-11 Branko Dipl Ing Klasnic Vorrichtung zum Entfernen von Rechengut aus einer mit einer verunreinigten Flüssigkeit durchströmten Zulaufrinne, insbesondere von Kläranlagen
GB9421836D0 (en) * 1994-10-28 1994-12-14 Scherer Corp R P Process for preparing solid pharmaceutical dosage forms of hydrophobic substances
GB9517062D0 (en) 1995-08-18 1995-10-25 Scherer Ltd R P Pharmaceutical compositions

Also Published As

Publication number Publication date
CA2229597C (en) 2004-02-10
ATE196249T1 (de) 2000-09-15
HUP9900183A3 (en) 1999-11-29
HUP9900183A2 (hu) 1999-05-28
BG102254A (en) 1998-10-30
MX9801305A (es) 1998-05-31
EE03471B1 (et) 2001-08-15
PT850050E (pt) 2001-01-31
NO313368B1 (no) 2002-09-23
JPH11511162A (ja) 1999-09-28
RU2189226C2 (ru) 2002-09-20
DK0850050T3 (da) 2000-10-16
AU709641B2 (en) 1999-09-02
DE69610323T2 (de) 2001-02-22
PL324988A1 (en) 1998-07-06
SK19198A3 (en) 1998-09-09
EP0850050A1 (en) 1998-07-01
PL187718B1 (pl) 2004-09-30
EE9800050A (et) 1998-08-17
ES2151672T3 (es) 2001-01-01
EP0850050B1 (en) 2000-09-13
NO980669D0 (no) 1998-02-17
HU222197B1 (hu) 2003-05-28
CZ45598A3 (cs) 1998-07-15
ZA967032B (en) 1997-03-04
CZ293129B6 (cs) 2004-02-18
NZ315740A (en) 1999-06-29
NO980669L (no) 1998-04-17
BG63188B1 (bg) 2001-06-29
US6316027B1 (en) 2001-11-13
BR9610424A (pt) 1999-03-30
AU6750996A (en) 1997-03-12
GB9517062D0 (en) 1995-10-25
UA64700C2 (en) 2004-03-15
WO1997006786A1 (en) 1997-02-27
SK283597B6 (sk) 2003-10-07
RO119066B1 (ro) 2004-03-30
CA2229597A1 (en) 1997-02-27
DE69610323D1 (de) 2000-10-19

Similar Documents

Publication Publication Date Title
GR3034583T3 (en) Oral fast-dissolving compositions for dopamine agonists
WO2001085257A3 (en) Opioid antagonist compositions and dosage forms
HUP0203451A2 (hu) Új, tuberkolózis elleni gyógyszerkészítmények és eljárás előállításukra
RU99117926A (ru) Лекарственные формы и способ лечения расстройства мужской эректильной функции
KR930007439A (ko) 방출 조절형 제약 조성물
YU35893A (sh) Formulacije oksidona sa kontrolisanim otpuštanjem i njihova upotreba
NO993520D0 (no) Doseringsformer og fremgangsmåte for å bedre erektil dysfunksjon
HUP0003405A2 (hu) Szabályozott hatóanyag-leadású, szublingvális vagy bukkális adagolású gyógyszerkészítmények
HUP0001894A2 (hu) N-Piperidino-3-pirazolkarboxamid-származékot, sóját vagy szolvátját tartalmazó orálisan adagolható gyógyszerkészítmény
MXPA03000548A (es) Combinacion novedosa de agonista (5-ht2) y antagonistas (5-ht6) de serotonina como formulacion farmaceutica.
AU780011B2 (en) Matrix tablet enabling the prolonged release of trimetazidine after administration by the oral route
NO20000466D0 (no) Farmasoeytisk preparat for sure, lipofile forbindelser i form av en selvemulgerende formulering
WO2006053089A3 (en) Methods and formulations for making pharmaceutical compositions containing bupropion
CA2378613A1 (en) Selective iglur5 receptor antagonists for the treatment of migraine
EP1064966A3 (en) Combination of an 5HT1 receptor antagonist, caffeine and a cyclooxygenase-2 inhibitor for the treatment of migraine
KR100253111B1 (en) Pharmaceutical compositions of alkylsulphonamides 5ht1 agonists for rectal administration
MXPA05008921A (es) Formulaciones orales semisolidas para liberacion inmediata que comprenden un agente hidrofobo anticancer, un glicerido poliglicolisado y un vehiculo hidrofilo.
EP1064948A3 (en) Combination of an 5HT1 receptor antagonist, caffeine and a cyclooxygenase-2 inhibitor for the treatment of migraine
TW200621314A (en) Methods and formulations for making pharmaceutical compositions containing bupropion
UA27784C2 (uk) Шипуча фармацевтична композиція для орального введення
JO1653B1 (en) The current benzimidazole is a therapeutically active method for preparing it